Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TARS | RARE | XENE | ||
| Company | Tarsus Pharmaceuticals Inc | Ultragenyx Pharmaceu | Xenon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 81.98 | 36.62 | 44.99 | ||
| High | 82.23 | 37.00 | 45.32 | ||
| Low | 80.65 | 35.94 | 44.79 | ||
| Latest | 81.59 | 36.80 | 44.94 | ||
| Change | -0.24 | +0.26 | +0.33 | ||
| % Change | -0.29% | +0.71% | +0.74% | ||
| Volume | 26,558 | 105,986 | 54,313 | ||
| 20-Day Average Volume | 387,632 | 1,195,104 | 740,792 | ||
| Previous Close | 81.83 | 36.54 | 44.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 77.37 | 33.41 | 41.79 | ||
| 20-Day Raw Stochastic | 85.58% | 86.44% | 96.17% | ||
| 20-Day Relative Strength | 64.38 | 59.59 | 63.85 | ||
| Weighted Alpha | +81.74 | -10.05 | +19.78 | ||
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.23% since 11/28/25 | +4.12% since 11/28/25 | +0.65% since 11/28/25 | ||
| Low | 77.44 on 12/01/25 | 33.16 on 12/02/25 | 42.35 on 12/02/25 | ||
| High | 82.90 on 12/04/25 | 37.25 on 12/04/25 | 45.32 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +18.68% since 11/05/25 | +13.52% since 11/05/25 | +16.43% since 11/05/25 | ||
| Low | 65.93 on 11/07/25 | 29.36 on 11/07/25 | 37.23 on 11/07/25 | ||
| High | 83.47 on 11/25/25 | 37.25 on 12/04/25 | 45.32 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +40.45% since 09/05/25 | +13.70% since 09/05/25 | +14.79% since 09/05/25 | ||
| Low | 48.20 on 09/15/25 | 27.75 on 09/25/25 | 35.60 on 09/15/25 | ||
| High | 83.47 on 11/25/25 | 37.25 on 12/04/25 | 45.32 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +83.62% since 06/05/25 | -1.98% since 06/05/25 | +46.47% since 06/05/25 | ||
| Low | 38.51 on 08/01/25 | 25.81 on 07/21/25 | 30.00 on 08/01/25 | ||
| High | 83.47 on 11/25/25 | 42.37 on 07/09/25 | 45.32 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,473,602 | 3,525,306 | 3,447,238 | ||
| Shares Outstanding, K | 42,449 | 96,478 | 77,275 | ||
| Annual Sales | 182,950,000 | 560,230,000 | 0 | ||
| Annual Net Income | -115,550,000 | -569,180,000 | -234,330,000 | ||
| Last Quarter Sales | 118,700,000 | 159,930,000 | 0 | ||
| Last Quarter Net Income | -12,590,000 | -180,410,000 | -84,710,000 | ||
| 60-Month Beta | 0.74 | 0.16 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 11/04/25 | -1.81 on 11/04/25 | -1.15 on 11/03/25 | ||
| Latest Earnings Date | 11/04/25 | 11/04/25 | 11/03/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||